Fundraising Fox

Forge Biologics

Grove City, US · Founded 2020 · Delaware LLC · 3 known investors

forgebiologics.com ↗

Forge Biologics is a US-based gene therapy CDMO (contract development and manufacturing organization) offering AAV manufacturing services, technologies, and infrastructure. It supports gene therapy developers across early development, clinical trials, and commercial production, and is a subsidiary of the Ajinomoto Group.

Advanced ManufacturingBiotechHealthtechMedical Devices

Founders & leadership

Forge Biologics was founded in 2020 by Timothy J. Miller.

TJ
Timothy J. MillerFounder

Board

CG
Chris GarabedianBoard director
MMMolly McCartin
Molly McCartinin𝕏Board Member2020–2023Partner at Drive Capital

Investors · 3

Aisling CapitalNew York
Drive CapitalColumbus · $5M – $30Mvia Molly Bonakdarpour · board
RA CapitalBoston

Reported raises · per SEC filings

Form D private placements

$160M disclosed across 2 rounds · 2020–2021

▶$120MraisedMay 2021 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederick CalloriDirector
  • Timothy J. MillerExecutive Officer, Director
  • Molly BonakdarpourDirector
  • Matthew HammondDirector
  • Chris GarabedianDirector
Offering amount
$120M
Amount sold
$120M
Sales commissions
$4.3M
First sale
Apr 2021
Incorporated
Limited Liability Company, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedAug 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris GarabedianDirector
  • Molly McCartinDirector
  • Timothy J. MillerExecutive Officer, Director
Offering amount
$40M
Amount sold
$40M
First sale
Jul 2020
Incorporated
Limited Liability Company, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Contract45 shared keywordsContract Pharma is a trade media publication covering the pharmaceutical and biopharmaceutical industry, with a focus on contract development and manufacturing (CDMO) topics. It provides industry news, magazine issues, expert interviews, webinars, whitepapers, company directories, and event coverage for professionals in the pharma and biopharma sector.

Companies competing with Forge Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Forge Biologics to Expand Manufacturing Facility | BioPharm Internationalbiopharminternational.com · Aug 2026Gene therapy startup Forge Biologics raises $90M on biotech manufacturing strength - Columbus Business Firstbizjournals.com · Sep 2022Funding is in Their Genes: Forge Biologics Raises $90M in Series Cpurpose.jobs · Sep 2022Forge Biologics Announces $90 Million Series C Financing to Expand Client Offerings and Add Services to Enhance End-to-End Gene Therapy Manufacturing Platforms - Forge Biologicsforgebiologics.com · Sep 2022Forge Biologics Raises $90M in Series C Financingfinsmes.com · Sep 2022

Frequently asked questions

What does Forge Biologics do?
Forge Biologics is a US-based gene therapy CDMO (contract development and manufacturing organization) offering AAV manufacturing services, technologies, and infrastructure. It supports gene therapy developers across early development, clinical trials, and commercial production, and is a subsidiary of the Ajinomoto Group.
Who founded Forge Biologics?
Forge Biologics was founded by Timothy J. Miller in 2020.
Who are Forge Biologics's investors?
Forge Biologics's investors include Aisling Capital, Drive Capital, RA Capital.
How much funding has Forge Biologics raised?
Forge Biologics has disclosed $160M raised across 2 rounds.
Where is Forge Biologics headquartered?
Forge Biologics is headquartered in Grove City, US.